Salestools LogoSalestools
Agents IA Salestools
Solutions
Ressources
Entreprise
Tarifs
Salestools Logo

Salestools

L'agent IA #1 pour les équipes de vente et Go-to-Market. Vendez plus, plus vite, avec moins d'effort.

Produit

  • Agents de vente IA
  • Données d'intention
  • Données technologiques
  • Suivi des visiteurs
  • Copilote
  • Vente sociale

Solutions

  • Service client
  • E-commerce
  • SaaS
  • Entreprise
  • Petite entreprise

Ressources

  • Le rapport
  • Documentation
  • Référence API
  • Centre d'aide
  • Blog
  • Études de cas
  • Webinaires

Entreprise

  • À propos
  • Carrières
  • Presse
  • Contact
  • Partenaires

Nos bureaux

  • New York, HQ
  • Bucarest, Laboratoire de recherche IA
  • Zug, Suisse

© 2026 Salestools. Tous droits réservés.

Conditions relatives aux données et sécuritéPolitique de confidentialitéConditions de serviceAcceptable Use
Tous les systèmes opérationnels
Salestools LogoSalestools
Agents IA Salestools
Solutions
Ressources
Entreprise
Tarifs
Back to Reports
Biotech

Retro Biosciences

Retro Biosciences raises $1B Growth at $2B valuation

San Mateo, CAJanuary 22, 20251 min read
Total Raised
$1B
Valuation
$2B
Latest Round
Growth
Employees
150+

Retro Biosciences: Growth Funding Round

Retro Biosciences has successfully raised $1B in Growth funding, reaching a valuation of $2B.

Company Overview

Extending healthy human lifespan

Funding Details

The Growth round was led by Sandro Salsano, with participation from Y Combinator.

Company Information

  • Headquarters: San Mateo, CA
  • Founded: 2021
  • Employees: 150+
  • Category: Biotech

Investment

Retro Biosciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

  • Sandro Salsano: Verified investor in Growth
  • Y Combinator: Verified investor in Growth

Company Info

Headquarters
San Mateo, CA
Founded
2021
Team Size
150+
Last Round
$1B(Jan 2025)

Investors (2)

S
Sandro SalsanoLead
Lead Investor
Verified investor in Growth
Y
Y Combinator
Investor
Verified investor in Growth

Topics

verified(3079)real-funding(3079)retro-biosciencesbiotechgrowthsan-mateo

Share

Related Reports

Biotech
AusperBio

AusperBio Raises $73M Series B

Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials

David Chen
David Chen
Dec 30, 2025
0 min read•$73M Series B
Biotech
Orna Therapeutics

Orna Therapeutics Raises $251M Series B

Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases

Emma Rodriguez
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics

Forge Biologics Raises $120M Series C

Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines

Sarah Kim
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free